Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/2/24 16:31 | 10/1/24 | RGNX | Health | BioPrd | Biological Products, (No Diag | Karabelas Argeris N | MD | D | 5 | S.d | -631 | 12.35 | 0 | -51 | 11 | D | ||||||||||||||||
8/5/24 18:39 | 8/1/24 | RGNX | Health | BioPrd | Biological Products, (No Diag | Simpson Curran | MD | DO | CEO | 2 | S | -147 | 15.04 | 0 | -10 | 170 | D | |||||||||||||||
7/26/24 17:00 | 7/24/24 | RGNX | Health | BioPrd | Biological Products, (No Diag | Mills Kenneth T. | MD | D | 8 | S.dm | -3,074 | 17.08 | 0 | -180 | 408 | D | ||||||||||||||||
3/7/24 18:05 | 3/5/24 | RGNX | Health | BioPrd | Biological Products, (No Diag | Pakola Steve | MD | O | Chief Me | 2 | S.d | -665 | 22.08 | 0 | -30 | 107 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |